1. Home
  2. TIL vs FEAM Comparison

TIL vs FEAM Comparison

Compare TIL & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • FEAM
  • Stock Information
  • Founded
  • TIL 2018
  • FEAM 2016
  • Country
  • TIL United States
  • FEAM United States
  • Employees
  • TIL N/A
  • FEAM N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • FEAM Major Chemicals
  • Sector
  • TIL Health Care
  • FEAM Industrials
  • Exchange
  • TIL Nasdaq
  • FEAM Nasdaq
  • Market Cap
  • TIL 230.1M
  • FEAM 71.5M
  • IPO Year
  • TIL 2021
  • FEAM N/A
  • Fundamental
  • Price
  • TIL $23.81
  • FEAM $3.50
  • Analyst Decision
  • TIL Buy
  • FEAM Strong Buy
  • Analyst Count
  • TIL 5
  • FEAM 2
  • Target Price
  • TIL $119.00
  • FEAM $121.00
  • AVG Volume (30 Days)
  • TIL 334.3K
  • FEAM 14.1K
  • Earning Date
  • TIL 08-12-2025
  • FEAM 05-15-2025
  • Dividend Yield
  • TIL N/A
  • FEAM N/A
  • EPS Growth
  • TIL N/A
  • FEAM N/A
  • EPS
  • TIL N/A
  • FEAM N/A
  • Revenue
  • TIL N/A
  • FEAM N/A
  • Revenue This Year
  • TIL N/A
  • FEAM N/A
  • Revenue Next Year
  • TIL N/A
  • FEAM N/A
  • P/E Ratio
  • TIL N/A
  • FEAM N/A
  • Revenue Growth
  • TIL N/A
  • FEAM N/A
  • 52 Week Low
  • TIL $9.62
  • FEAM $2.82
  • 52 Week High
  • TIL $92.00
  • FEAM $30.36
  • Technical
  • Relative Strength Index (RSI)
  • TIL 45.83
  • FEAM 37.85
  • Support Level
  • TIL $20.60
  • FEAM $3.41
  • Resistance Level
  • TIL $31.67
  • FEAM $3.82
  • Average True Range (ATR)
  • TIL 3.53
  • FEAM 0.25
  • MACD
  • TIL -1.54
  • FEAM -0.02
  • Stochastic Oscillator
  • TIL 17.93
  • FEAM 17.65

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

Share on Social Networks: